Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Clinical trial NCT06567769 · RECRUITING
Trial details
- NCT number
- NCT06567769
- Sponsor
- GC Biopharma Corp
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2027-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.